[Federal Register Volume 88, Number 74 (Tuesday, April 18, 2023)]
[Notices]
[Pages 23678-23679]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-08246]



[[Page 23678]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2023-0028]


Advisory Committee on Immunization Practices (ACIP)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC) announces the following meeting of 
the Advisory Committee on Immunization Practices (ACIP). This meeting 
is open to the public. Time will be available for public comment.

DATES: The meeting will be held on April 19, 2023, 11 a.m. to 3 p.m., 
EDT (date and times subject to change; see the ACIP website for 
updates: https://www.cdc.gov/vaccines/acip/index.htm).
    Written comments must be received on or before April 19, 2023.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0028, by either of the methods listed below. CDC does not accept 
comments by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: ACIP Meeting, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta, Georgia 
30329-4027. Attn: Docket No. CDC-2023-0028.
    Instructions: All submissions received must include the Agency name 
and docket number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.
    The meeting will be webcast live via the World Wide Web. The 
webcast link can be found on the ACIP website at https://www.cdc.gov/vaccines/acip/index.html.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management 
Specialist, Advisory Committee on Immunization Practices, National 
Center for Immunization and Respiratory Diseases, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta, 
Georgia 30329-4027. Telephone: (404) 639-8836; Email: [email protected].

SUPPLEMENTARY INFORMATION: Fewer than 15 calendar days' notice is being 
given for this meeting in accordance with 41 CFR 102-3.150(b). 
Following a discussion between CDC and the Food and Drug Administration 
regarding anticipated regulatory changes to the COVID-19 vaccination 
program, a decision was made late Monday, April 10, 2023, that it is 
essential for ACIP to have a public committee meeting to discuss and 
get input from the Committee members. This meeting is critical in order 
for the rationale for these changes to be conveyed to the public in a 
timely and efficient manner. Further, given the continuing COVID-19 
pandemic, it is essential that all decision-making regarding vaccines 
be done as urgently as possible. A notice of the meeting has also been 
posted on the ACIP website at https://www.cdc.gov/vaccines/acip/index.html. In addition, CDC has sent notice of the meeting by email to 
those who subscribe to receive email updates about ACIP.
    Purpose: The Advisory Committee on Immunization Practices (ACIP) is 
charged with advising the Director, Centers for Disease Control and 
Prevention (CDC), on the use of immunizing agents. In addition, under 
42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
For Children program, along with schedules regarding dosing interval, 
dosage, and contraindications to administration of vaccines. Further, 
under applicable provisions of the Affordable Care Act and section 2713 
of the Public Health Service Act, immunization recommendations of ACIP 
that have been approved by the Director, CDC, and appear on CDC 
immunization schedules generally must be covered by applicable health 
plans.
    Matters To Be Considered: The agenda will include discussions on 
COVID-19 vaccines. No recommendation votes are scheduled. Agenda items 
are subject to change as priorities dictate. For more information on 
the meeting agenda, visit https://www.cdc.gov/vaccines/acip/meetings/index.html.
    Meeting Information: The meeting will be webcast live via the World 
Wide Web. For more information on ACIP, please visit the ACIP website: 
https://www.cdc.gov/vaccines/acip/index.html.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on https://www.regulations.gov. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name, contact information, or other 
information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near-duplicate 
examples of a mass-mail campaign. CDC will carefully consider all 
comments submitted into the docket.
    Written Public Comment: Written comments must be received on or 
before April 19, 2023.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Priority will be given to 
individuals who submit a request to make an oral public comment before 
the meeting according to the procedures below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the April 19, 2023, ACIP meeting must submit 
a request at https://www.cdc.gov/vaccines/acip/meetings/index.html no 
later than 11:59 p.m., EDT, April 17, 2023, according to the 
instructions provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email on April 18, 2023. To accommodate the significant 
interest in participation in the oral public comment session of ACIP 
meetings, each speaker will be limited to three minutes, and each 
speaker may only speak once per meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and

[[Page 23679]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-08246 Filed 4-14-23; 4:15 pm]
BILLING CODE 4163-18-P